Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02614794 |
|---|---|
| Brief Title: | A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer (HER2CLIMB) |
| First Submitted : | November 20, 2015 |
| First Submitted that Met QC Criteria : | November 23, 2015 |
| First Posted : | November 25, 2015 (Estimate) |
| Results First Submitted : | September 4, 2020 |
| Results First Submitted that Met QC Criteria : | September 4, 2020 |
| Results First Posted : | September 28, 2020 |
| Last Update Submitted that Met QC Criteria : | August 23, 2022 |
| Last Update Posted : | September 13, 2022 |